FDA official logo
GSRS logoPFDA official logo

PALOPEGTERIPARATIDE

UNII:G2N64C3385
Type:INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:PALOPEGTERIPARATIDE
GSRS Full Record:
G2N64C3385
i

  • 2222514-07-8
  • ACP-014
  • Human parathyroid hormone (PTH) synthetic peptide fragment (1-34), conjugated at the N-terminal amino group via a cleavable linker to O-methylpolyethylene glycol (2 x 20 kDa mPEG); 2-methylalanyl-(1-34)-peptide of parathyroid hormone (Homo sapiens parathyrin, parathormone, PTH) conjugated with O-methylpolyethylene glycol via a cleavable linker at the N-terminal amino group: N-({2-[(6-{[(3RS)-1-{3-[(3-{(2Ξ)-2,3-bis[αmethylpoly(oxyethylene)-ω-oxy]propoxy}propyl)amino]-3- oxopropyl}-2,5-dioxopyrrolidin-3- yl]sulfanyl}hexyl)amino]ethyl}carbamoyl)-2-methylalanyl-Lseryl-L-valyl-L-seryl-L-α-glutamyl-L-isoleucyl-L-glutaminyl-Lleucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-Llysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-Lα-glutamyl-L-arginyl-L-valyl-L-α-glutamyl-L-tryptophyl-Lleucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-αaspartyl-L-valyl-L-histidyl-L-asparaginyl-L-phenylalanine
  • MPEG 40000-TERIPARATIDE
  • PALOPEGTERIPARATIDE [USAN]
  • Palopegteriparatide [MI]
  • Palopegteriparatide [WHO-DD]
  • Poly(oxy-1,2-ethanediyl), α-hydro-ω-methoxy-, ether with N-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-L-seryl-L-valyl-L-seryl-L-α-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-α-glutamyl-L-arginyl-L-valyl-L-α-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-valyl-L-histidyl-L-asparaginyl-L-phenylalanine (2:1)
  • TRANSCON PARATHYROID HORMONE (1-34)
  • TRANSCON PTH (1-34)
  • YORVIPATH
  • palopegteriparatide [INN]




UNII - G2N64C3385 | UNII Search Service